Supernus sues Par over proposed Trokendi generic

20-01-2015

Supernus sues Par over proposed Trokendi generic

Adrian Niederhaeuser / Shutterstock.com

US-based Supernus Pharmaceuticals has sued generic drug maker Par Pharmaceutical for allegedly infringing four patents covering its extended release anti-epileptic drug Trokendi XR (topiramate), the company announced on Friday (January 16).


Supernus Pharmaceuticals, Trokendi XR, Par Pharmaceutical, US District Court for the District of New Jersey, ANDA

LSIPR